期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (4)
In December 2019, the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the outbreak of coronavirus disease 2019 (COVID-19), a......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (2)
Focal nodular hyperplasia (FNH) is a solid benign tumor of the liver, predominantly in young women. A correct diagnosis of FNH is essential for making......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (4)
Combined antiretroviral therapy (cART) has significantly reduced human immunodeficiency virus (HIV) associated morbidity and mortality and turned HIV ......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (3)
Alzheimer's disease (AD) is an irreversible brain disorder associated with severe progressive dementia and is characterized by deposits of amyloid pla......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (3)
The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharma......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2021; 15 (1)
Cancer is still a major factor threatening human life around the world, and anticancer drugs remain a huge unmet clinical need. Here, we reviewed nove......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (6)
The 2022 monkeypox outbreak outside Africa is ongoing. Cases have been reported in Hong Kong and Chongqing, China. In order to better prevent and cont......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (6)
Adult T-cell leukemia/lymphoma (ATL) is a mature T-cell lymphoma with a poor prognosis. Accumulating trimethylation of histone H3 lysine 27 (H3K27me3)......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (2)
Individuals in close contact with multidrug-resistant tuberculosis (MDR-TB) patients are subject to an elevated risk of infection, and may develop lat......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (3)
The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a high rate of transmission and it exhibits immune escape char......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (6)
Gemcitabine is widely used in the clinic as a first-line antitumor agent. However, intrinsic and acquired resistance hinders its wide clinical applica......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (6)
Clinical diagnosis of tuberculosis (TB) in people living with the human immunodeficiency virus (HIV) poses a challenge. The Xpert MTB/RIF Ultra (Ultra......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (2)
Tuberculosis has become a great global public health threat. Compared with drug-susceptible tuberculosis (TB), the treatment regimens for multidrug-re......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (4)
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired clonal hematopoietic stem cell disorder, characterized by hemolytic anemia, bone marrow ......
期刊： DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (2)
Hepatitis B virus genotype C (HBV/C) is one of the most prevalent HBV strains worldwide, especially in the Western Pacific and the South-East Asia. Ho......
